Skip to main content

New Products

  • Sephora launches YOU+Sephora cosmetics collection to benefit charities

    SAN FRANCISCO — Following the launch of Values Inside Out, Sephora's charitable platform has presented the first limited-edition cosmetic collection to benefit its nonprofit partners. 

  • Perfecta Products reformulates Zim's Max-Freeze

    NORTH LIMA, Ohio — Perfecta Products on Tuesday announced the reformulation of Zim's Max-Freeze, which no longer contains such ingredients as parabens, sulfates or coloring. Ingredients now include certified organic ilex, arnica and aloe with a greaseless, stain-free formula.  

  • Advancing pharmacy management service

    Like drinking from a fire hose. That’s one way some pharmacy retailers might describe their efforts to manage the flood of data unleashed every day by their prescription dispensing operations. The goal: to turn that data flow into actionable information they can use to better manage pharmacy workflow and staff resources, boost profitability, reduce customer wait times and make more informed decisions about the capital every retail pharmacy must allocate to technology and staffing.

  • J&J plans slew of regulatory filings through 2017

    NEW BRUNSWICK, N.J. — Johnson & Johnson expects to file for Food and Drug Administration approval of more than 10 new drugs over the next four years, the drug maker said Thursday.

    J&J's Janssen Pharmaceutical Cos. highlighted its more than 11 new product launches since 2009 and said it hoped to file with the FDA for more than two-dozen "significant" extensions to its branded drug lines by 2017.

  • Kathy Ireland helps launch stem-cell derived beauty line

    LOS ANGELES — Kathy Ireland, CEO and chief designer of Kathy Ireland Worldwide and women’s health advocate, is collaborating with board-certified surgeon Dr. David Scharp in bringing to the beauty market a stem cell-derived product brand called Stemáge.

    They note that the unique aspect of the natural skin rejuvenation system is that it targets visible signs of aging through the proprietary use of human Mesenchymal stem cell derivatives, not stem cells but rather active ingredients or derivatives of which stem cells are comprised.

  • More than half of doctor's offices adopt electronic health records

    WASHINGTON — More than half of all healthcare providers who are eligible have received Medicare and Medicaid incentive payments for electronic health records, the Department of Health and Human Services said.

    HHS secretary Kathleen Sebelius said the department had exceeded its goal for 50% of doctor offices and 80% of hospitals to have EHRs by the end of the year. By contrast, the percentage of physicians using EHRs in 2008 was 17%. The American Recovery and Reinvestment Act of 2009 contained incentive programs for adoption of EHRs that went into effect in 2011.

  • Red Carpet Manicure launches light-activated nail treatments

    HAUPPAUGE, N.Y. — Red Carpet Manicure, which manufactures an at-home LED gel manicure system, has officially unveiled its new nail, cuticle and hand treatments.

    At a press event in New York City on Wednesday, the company highlighted the five-item collection, which is the first of its kind, DIY light-activated gel nail treatment to help nails become stronger and longer. The treatments are priced at $14.99 each.

  • Par ships authorized generic cardiovascular drug

    WOODCLIFF LAKE, N.J. — Generic drug maker Par Pharmaceutical Cos. has started shipping an authorized generic version of a heart-disease medication made by AstraZeneca.

    Par said it had entered into an agreement with AstraZeneca to supply authorized generic Atacand (candesartan cilexetil) and had begun shipping the drug in the 4 mg, 8 mg, 16 mg and 32 mg strengths. Atacand has annual sales of about $113 million, according to IMS Health, and is used to treat certain kinds of heart failure and high blood pressure in children and adults.

X
This ad will auto-close in 10 seconds